Regencell Bioscience Holdings (RGC) Market Capitalization (2022 - 2025)

Regencell Bioscience Holdings (RGC) has reported Market Capitalization for 4 consecutive years, with $273.3 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Market Capitalization changed N/A year-over-year to $273.3 million; the trailing twelve-month figure through Dec 2025 stood at $273.3 million (changed N/A YoY), and the FY2025 full-year result was $221.7 million, up 19176.02% from the prior year.
• Market Capitalization rose to $273.3 million in Q4 2025 per RGC's latest filing, from $221.7 million in the prior quarter.
• Across five years, Market Capitalization topped out at $273.3 million in Q4 2025 and bottomed at $1.2 million in Q2 2024.
• Historically, Market Capitalization has averaged $103.2 million across 4 years, with a median of $11.9 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization sank 85.42% in 2024, then soared 19176.02% in 2025.
• Over 4 years, Market Capitalization stood at $11.9 million in 2022, then sank by 33.42% to $7.9 million in 2023, then tumbled by 85.42% to $1.2 million in 2024, then surged by 23655.66% to $273.3 million in 2025.
• According to Business Quant data, Market Capitalization over the past three periods registered $273.3 million, $221.7 million, and $1.2 million for Q4 2025, Q2 2025, and Q2 2024 respectively.